Global Vaccine Market Expected to Reach $50.52 billion by 2023
The value of the vaccine market will reach $50.42 billion by 2023 from $36.45 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 6.7 percent, according to recently published report by private research firm MarketsandMarkets of India.1 The report provides an overview of the global vaccine market estimating the market size and potential for […]
Vaccines are the Victims of Their Own Success?
One of the most common explanations given by supporters of vaccine mandates for why a growing number of people are having second thoughts about vaccination is that vaccines have been so successful in defeating infectious diseases that people forget how bad things were before vaccines. In a recent BMJ opinion piece, Giovanni Rezza, MD of […]
Doctors, Money, and Conflicts of Interest
I’m a doctor. My father’s a doctor. My colleagues are doctors. The people I train are doctors. Lots and lots of my friends are doctors. But that doesn’t mean that doctors sometimes are not blind to certain issues, like their own financial conflicts of interest. Sometimes we have to poke doctors with a stick. That’s […]
Soft-Pedaling the Unintended Consequences of Vaccination
There are a few terms that are commonly used to describe an undesired outcome of a vaccination. Perhaps the most common one is “side effect.” The Merriam-Webster dictionary defines side effect as “a secondary and usually adverse effect (as of a drug)”—as in “toxic side effects—called also side reaction.”1 MedicineNet defines an “adverse effect” as, “A harmful or […]
CDC Accused of Manipulating Shingles Data
The varicella zoster (chickenpox) virus causes a generally mild and short-lived disease when it occurs in young children under age 12, as it almost always did prior to the live attenuated varicella vaccine being licensed in 1995 and recommended by the Centers for Disease Control and Prevention (CDC) for use by all children.1 Natural chickenpox […]
Goldman Sachs Exposes the Cure Dilemma
Story Highlights New gene therapies offer unprecedented hope for permanent cures of serious diseases and hold the promise of an invaluable societal impact. In a report to their biotech clients, investment giant Goldman Sachs questions whether curative therapies are a viable business model. Using Gilead Science’s hepatitis C drug as an example, the report noted […]